Current Treatment Insights
Treatment landscape analysis insight report describes the current treatment and management of a specific disease area. The analysis includes various current approved and off-label therapies, their respective doses, durations, efficacy, and safety benchmarks. The use of treatments by a line of therapy, including their KOL-perceived advantages and disadvantages, are studied. In addition, an in-depth assessment of patient characteristics, diagnosis, comorbidities, and their treatment, including treatment switches, polypharmacy, compliance, and persistence, is conducted.
Key outcomes:
- What are the currently available therapies for the specific disease area in the G8 markets (US, EU5, Japan, China)?
- What are the patient shares for current therapies in various lines of treatment?
- What key factors influence physicians to prescribe brands for managing the condition?
- What are the obstacles preventing physicians from using brands for managing the condition?
- How do physician practices align or differ from the treatment guidelines?
- What are KOL expectations from emerging therapies to overcome the challenges of current therapies?
Reports:
Need customize support?
Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.